{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["BDW", "Bacopa monnier", "Dementia", "Hupergene", "Omega-3", "Palmitoylethanolamide", "Souvenaid", "Tramiprostate", "Yokukansan"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38533051", "DateRevised": {"Year": "2024", "Month": "03", "Day": "28"}, "Article": {"Language": ["eng"], "ELocationID": ["e27233", "10.1016/j.heliyon.2024.e27233"], "ArticleDate": [{"Year": "2024", "Month": "02", "Day": "27"}], "Journal": {"ISSN": "2405-8440", "JournalIssue": {"Volume": "10", "Issue": "6", "PubDate": {"Year": "2024", "Month": "Mar", "Day": "30"}}, "Title": "Heliyon", "ISOAbbreviation": "Heliyon"}, "ArticleTitle": "Therapeutic potential of clinically proven natural products in the management of dementia.", "Pagination": {"StartPage": "e27233", "MedlinePgn": "e27233"}, "Abstract": {"AbstractText": ["Dementia is a common neurodegenerative disorder connected to damage to nerve cells in the brain. Although some conventional drugs are available for dementia treatments and are still sanctified for dementia patients, their short- and long-term side effects and other limitations make treating patients more challenging. The authors aimed to explain novel options for treating dementia with natural products and unravel some clinically proven natural products. This article systematically reviewed recent studies that have investigated the role of natural products and their bioactive compounds for dementia. PubMed Central, Scopus, and Google Scholar databases of articles were collected, and abstracts were reviewed for relevance to the subject matter.In this review, we provide mechanistic insights of clinically validated natural products, including like- Yokukansan, Souvenaid, BDW, Hupergene, <i>Bacopa monnier</i>, Omega-3, Tramiprostate and Palmitoylethanolamide with which have therapeutic efficacy against dementia in the management of dementia. As shown by studies, certain natural ingredients could be used to treat and prevent dementia. We strongly believe that the medicinal plants and phytoconstituents alone or in combination with other compounds would be effective treatments against dementia with lesser side effects as compared to currently available treatments. Moreover, these products should be studied further in order to develop novel dementia medications."], "CopyrightInformation": "\u00a9 2024 Published by Elsevier Ltd."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Molecular Biology, Laboratory of Nutrition and Health Research, University of Dhaka, Dhaka, 1000, Bangladesh."}], "LastName": "Ansari", "ForeName": "Farzana", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry and Molecular Biology, Mawlana Bhashani Science and Technology University, Santosh, Tangail, 1902, Bangladesh."}, {"Identifier": [], "Affiliation": "Pratyasha Health Biomedical Research Center, Dhaka, 1230, Bangladesh."}], "LastName": "Sohel", "ForeName": "Md", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Primeasia University, Dhaka, 1213, Bangladesh."}], "LastName": "Haidary", "ForeName": "Md Mahfujul Haque", "Initials": "MMH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, University of Asia Pacific, Dhaka, 1205, Bangladesh."}], "LastName": "Mostaq", "ForeName": "Md Saqline", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Atish Dipankar University of Science and Technology, Dhaka, 1230. Bangladesh."}], "LastName": "Akter", "ForeName": "Shamima", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Atish Dipankar University of Science and Technology, Dhaka, 1230. Bangladesh."}], "LastName": "Nahar", "ForeName": "Asrafun", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Faculty of Pharmacy, University of Dhaka, Dhaka, 1000, Bangladesh."}], "LastName": "Labony", "ForeName": "Fatematuz Zohora", "Initials": "FZ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Noakhali Science and Technology University, Noakhali, 3814, Bangladesh."}], "LastName": "Ahmed", "ForeName": "Arman", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Noakhali Science and Technology University, Noakhali, 3814, Bangladesh."}], "LastName": "Hasan", "ForeName": "Mohammed Shamim", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacy, Atish Dipankar University of Science and Technology, Dhaka, 1230. Bangladesh."}], "LastName": "Babu", "ForeName": "Mohammad Hasem", "Initials": "MH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pratyasha Health Biomedical Research Center, Dhaka, 1230, Bangladesh."}, {"Identifier": [], "Affiliation": "Department of Pharmacy, Atish Dipankar University of Science and Technology, Dhaka, 1230. Bangladesh."}], "LastName": "Amin", "ForeName": "Mohammad Nurul", "Initials": "MN"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Heliyon", "NlmUniqueID": "101672560", "ISSNLinking": "2405-8440"}, "CoiStatement": "The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Holmes C., Amin J. Dementia, Medicine (United Kingdom) 2020;48(11):742\u2013745. doi: 10.1016/j.mpmed.2020.08.014.", "ArticleIdList": ["10.1016/j.mpmed.2020.08.014"]}, {"Citation": "Arvanitakis Z., Bennett D.A. \u201cWhat is dementia? JAMA. 2019;322(17):1728. doi: 10.1001/jama.2019.11653.", "ArticleIdList": ["10.1001/jama.2019.11653", "PMC7455009", "31688886"]}, {"Citation": "D. UK. 2020. What Is Dementia? - Dementia UK, what Is Dementia?"}, {"Citation": "Kasl-Godley J., Gatz M. Psychosocial interventions for individuals with dementia: an integration of theory, therapy, and a clinical understanding of dementia. Clin. Psychol. Rev. 2000;20(6):755\u2013782. doi: 10.1016/S0272-7358(99)00062-8.", "ArticleIdList": ["10.1016/S0272-7358(99)00062-8", "10983267"]}, {"Citation": "Geda Y.E., Schneider L.S., Gitlin L.N., Miller D.S., Smith G.S., Bell J. Geda et al., Neuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the future. Alzheimer's Dementia. 2013;9(5):602\u2013608. doi: 10.1016/j.jalz.2012.12.001.", "ArticleIdList": ["10.1016/j.jalz.2012.12.001", "PMC3766403", "23562430"]}, {"Citation": "Finkel S.I., Costa e Silva J., Cohen G., Miller S., Sartorius N. Behavioral and psychological signs and symptoms of dementia: a consensus statement on current knowledge and implications for research and treatment. Int. Psychogeriatr. 1996;8:497\u2013500. doi: 10.1017/S1041610297003943.", "ArticleIdList": ["10.1017/S1041610297003943", "9154615"]}, {"Citation": "Livingston G., Sommerlad A., Orgeta V., Costafreda S.G., Huntley J., Ames D., et al. Dementia prevention, intervention, and care. Lancet. 2017;390(10113):2673\u20132734. doi: 10.1016/S0140-6736(17)31363-6.", "ArticleIdList": ["10.1016/S0140-6736(17)31363-6", "28735855"]}, {"Citation": "Prince M., Bryce R., Albanese E., Wimo A., Ribeiro W., Ferri C.P. The global prevalence of dementia: a systematic review and metaanalysis. Alzheimer's Dementia. 2013;9(1) doi: 10.1016/j.jalz.2012.11.007.", "ArticleIdList": ["10.1016/j.jalz.2012.11.007", "23305823"]}, {"Citation": "Arvanitakis Z., Shah R.C., Bennett D.A. Diagnosis and management of dementia: review. JAMA. 2019;322(16):1589\u20131599. doi: 10.1001/jama.2019.4782.", "ArticleIdList": ["10.1001/jama.2019.4782", "PMC7462122", "31638686"]}, {"Citation": "Organisation W.H. Geneva World Heal. Organ.; 2017. Global Action Plan on the Public Health Response to Dementia 2017 - 2025."}, {"Citation": "Goodman R.A., Lochner K.A., Thambisetty M., Wingo T.S., Posner S.F., Ling S.M. Prevalence of dementia subtypes in United States Medicare fee-for-service beneficiaries, 2011\u20132013. Alzheimer's Dementia. 2017;13(1):28\u201337. doi: 10.1016/j.jalz.2016.04.002.", "ArticleIdList": ["10.1016/j.jalz.2016.04.002", "PMC5104686", "27172148"]}, {"Citation": "Prince M., Knapp M., Guerchet M., McCrone P., Prina M., Comas-Herrera, et al. second ed. Update; 2014. Dementia UK."}, {"Citation": "Wu Y.T., Ali G.C., Guerchet M., Prina A.M., Chan K.Y., Prince M., et al. Prevalence of dementia in mainland China, Hong Kong and Taiwan: an updated systematic review and meta-analysis. Int. J. Epidemiol. 2018;47(3):709\u2013719. doi: 10.1093/ije/dyy007.", "ArticleIdList": ["10.1093/ije/dyy007", "PMC6005065", "29444280"]}, {"Citation": "Guerchet M., Prina M., Prince M. Policy Br. Heads Gov. Glob. Impact Dement. 2013\u20132050 Publ. By Alzheimer's Dis. Int. (ADI), London. December 2013. Policy brief for heads of government: the global impact of dementia 2013\u2013205\u201c; p. 2013."}, {"Citation": "Gyawali R., Ibrahim S.A. Natural products as antimicrobial agents. Food Control. 2014:412\u2013429. doi: 10.1016/j.foodcont.2014.05.047.", "ArticleIdList": ["10.1016/j.foodcont.2014.05.047"]}, {"Citation": "Sohel M. Comprehensive exploration of Biochanin A as an oncotherapeutics potential in the treatment of multivarious cancers with molecular insights. Phytother Res. 2024;38(2):489\u2013506. doi: 10.1002/ptr.8050.", "ArticleIdList": ["10.1002/ptr.8050", "37905329"]}, {"Citation": "Sohel M., Sultana H., Sultana T., Al Amin M., Aktar S., Ali M.C., et al. Chemotherapeutic potential of hesperetin for cancer treatment, with mechanistic insights: a comprehensive review. Heliyon. 2022;8(1) doi: 10.1016/j.heliyon.", "ArticleIdList": ["10.1016/j.heliyon", "PMC8810372", "35128104"]}, {"Citation": "Sohel M., Biswas P., Al Amin M., Hossain M.A., Sultana H., Dey D., et al. Genistein, a potential phytochemical against breast cancer treatment-insight into the molecular mechanisms. Processes. 2022;10(2):415. doi: 10.3390/pr10020415.", "ArticleIdList": ["10.3390/pr10020415"]}, {"Citation": "Sohel M., Zahra Shova F.T., Shuvo S., Mahjabin T., Mojnu Mia M., Halder D., et al. Unveiling the potential anti-cancer activity of calycosin against multivarious cancers with molecular insights: a promising frontier in cancer research. Cancer Med. 2024:1\u201326. doi: 10.1002/cam4.6924.", "ArticleIdList": ["10.1002/cam4.6924", "PMC10905684", "38230908"]}, {"Citation": "Biswas P., Dey D., Biswas P.K., Rahaman T.I., Saha S., Parvez A., et al. A comprehensive analysis and anti-cancer activities of quercetin in ROS-mediated cancer and cancer stem cells. Int. J. Mol. Sci. 2022;23(19):1\u201333. doi: 10.3390/ijms231911746.", "ArticleIdList": ["10.3390/ijms231911746", "PMC9569933", "36233051"]}, {"Citation": "Mitra S., Dash R., Sohel M., Chowdhury A., Munni Y.A., Ali M.C., Hannan M.A., et al. Targeting estrogen signaling in the radiation-induced neurodegeneration: possible role of phytoestrogens. Curr. Neuropharmacol. 2022;21(2):353\u2013379. 10.2174/1570159X20666220310115004 2022.", "ArticleIdList": ["PMC10190149", "35272592"]}, {"Citation": "Paul Priyanka, Biswas Partha, Dey Dipta, Abu Saim Mohammad Saikat, Islam Md Aminul, Sohel Md, Hossain Rajib, et al. Exhaustive plant profile of \u201cdimocarpus longan lour\u201d with significant phytomedicinal properties: a literature based-review. Processes. 2021;9(10):1803. doi: 10.3390/pr9101803.", "ArticleIdList": ["10.3390/pr9101803"]}, {"Citation": "Xia X., Liu Y., Chen Z., Li A., Liu R., Yang H. The phytochemical potential for brain disease therapy and the possible nanodelivery solutions for brain access. Front. Oncol. 2022:1\u201311. doi: 10.3389/fonc.2022.936054.", "ArticleIdList": ["10.3389/fonc.2022.936054", "PMC9259986", "35814371"]}, {"Citation": "Sahebnasagh A., Eghbali S., Saghafi F., Sureda A., Avan R. Neurohormetic phytochemicals in the pathogenesis of neurodegenerative diseases. Immun. Ageing. 2022;19(1):1\u201316. doi: 10.1186/s12979-022-00292-x.", "ArticleIdList": ["10.1186/s12979-022-00292-x", "PMC9367062", "35953850"]}, {"Citation": "Prabhu Jai, Prabhu K., Chaudhuri Anathbandhu, Krishna Rao Mudiganti Ram, Kalai Selvi V.S., Balaji T.K., et al. Neuro-protective effect of ayurveda formulation, saraswatharishtam, on scopolamine induced memory impairment in animal model. Phcog. J. 2020;12(3):1\u20138. doi: 10.5530/pj.2020.12.72.", "ArticleIdList": ["10.5530/pj.2020.12.72"]}, {"Citation": "Trovato Salinaro A., Pennisi M., Di Paola R., Scuto M., Crupi R., Cambria M.T., et al. Neuroinflammation and neurohormesis in the pathogenesis of Alzheimer's disease and Alzheimer-linked pathologies: modulation by nutritional mushrooms. Immun. Ageing. 2018;15(1):1\u20138. doi: 10.1186/s12979-017-0108-1.", "ArticleIdList": ["10.1186/s12979-017-0108-1", "PMC5813410", "29456585"]}, {"Citation": "Eghbali S., Askari S.F., Avan R., Sahebkar A. Therapeutic effects of Punica granatum (pomegranate): an updated review of clinical trials. Journal of Nutrition and Metabolism. 2021;2021:1\u201322. doi: 10.1155/2021/5297162.", "ArticleIdList": ["10.1155/2021/5297162", "PMC8595036", "34796029"]}, {"Citation": "de Andrade Teles R.B., Diniz T.C., Costa Pinto T.C., de Oliveira J\u00fanior R.G., Gama E Silva M., de Lavor \u00c9.M., et al. Flavonoids as therapeutic agents in Alzheimer's and Parkinson's diseases: a systematic review of preclinical evidences. Oxid. Med. Cell. Longev. 2018;10:1\u201321. doi: 10.1155/2018/7043213.", "ArticleIdList": ["10.1155/2018/7043213", "PMC5971291", "29861833"]}, {"Citation": "Lei HP, Ji W, Lin J, Chen H, Tan ZR, Hu DL, Liu LJ, Zhou HH et al., Effects of Ginkgo biloba extract on the pharmacokinetics of bupropion in healthy volunteers, Br. J. Clin. Pharmacol. 68(2(2)009) 201\u2013206, doi: 10.1111/j.1365-2125.2009.03442.x.", "ArticleIdList": ["PMC2767283", "19694739"]}, {"Citation": "Ude C., Schubert-Zsilavecz M., Wurglics M. Ginkgo biloba extracts: a review of the pharmacokinetics of the active ingredients. Clin. Pharmacokinet. 2013;52(9):727\u2013749. doi: 10.1007/s40262-013-0074-5.", "ArticleIdList": ["10.1007/s40262-013-0074-5", "23703577"]}, {"Citation": "Shi J., He M., Cao J., Wang H., Ding J., Jiao Y., et al. The comparative analysis of the potential relationship between resveratrol and stilbene synthase gene family in the development stages of grapes (Vitis quinquangularis and Vitis vinifera) Plant Physiol. Biochem. 2014;74:24\u201332. doi: 10.1016/j.plaphy.2013.10.021.", "ArticleIdList": ["10.1016/j.plaphy.2013.10.021", "24246671"]}, {"Citation": "Kim J., Lee H.J., Lee K.W. Naturally occurring phytochemicals for the prevention of Alzheimer's disease. J. Neurochem. 2010;112(6):24\u201332. doi: 10.1111/j.1471-4159.2009.06562.x.", "ArticleIdList": ["10.1111/j.1471-4159.2009.06562.x", "20050972"]}, {"Citation": "Mandel S., Amit T., Reznichenko L., Weinreb O., Youdim M.B.H. Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders. Mol. Nutr. Food Res. 2006;50(2):229\u2013234. doi: 10.1002/mnfr.200500156.", "ArticleIdList": ["10.1002/mnfr.200500156", "16470637"]}, {"Citation": "Chakrawarti L., Agrawal R., Dang S., Gupta S., Gabrani R. Therapeutic effects of EGCG: a patent review. Expert Opin. Ther. Pat. 2016;26(8):907\u2013916. doi: 10.1080/13543776.2016.1203419.", "ArticleIdList": ["10.1080/13543776.2016.1203419", "27338088"]}, {"Citation": "Williams R.J., Spencer J.P.E. Flavonoids, cognition, and dementia: actions, mechanisms, and potential therapeutic utility for Alzheimer disease. Free Radic. Biol. Med. 2012;52(1):35\u201345. doi: 10.1016/j.freeradbiomed.2011.09.010.", "ArticleIdList": ["10.1016/j.freeradbiomed.2011.09.010", "21982844"]}, {"Citation": "Grassi D., Ferri C., Desideri G. Brain protection and cognitive function: cocoa Flavonoids as nutraceuticals. Curr. Pharmaceut. Des. 2015;22(2):145\u2013151. doi: 10.2174/1381612822666151112145730.", "ArticleIdList": ["10.2174/1381612822666151112145730", "26561075"]}, {"Citation": "Sivaramakrishna C., Rao C.V., Trimurtulu G., Vanisree M., Subbaraju G.V. Triterpenoid glycosides from Bacopa monnieri. Phytochemistry. 2005;66(23):2719\u20132728. doi: 10.1016/j.phytochem.2005.09.016.", "ArticleIdList": ["10.1016/j.phytochem.2005.09.016", "16293276"]}, {"Citation": "Schmidt M., Betti G., Hensel A. Saffron in phytotherapy: pharmacology and clinical uses. Wien Med. Wochenschr. 2007;157(13\u201314):315\u2013319. doi: 10.1007/s10354-007-0428-4.", "ArticleIdList": ["10.1007/s10354-007-0428-4", "17704979"]}, {"Citation": "Ullah F., Liang A., Rangel A., Gyengesi E., Niedermayer G., M\u00fcnch G. High bioavailability curcumin: an anti-inflammatory and neurosupportive bioactive nutrient for neurodegenerative diseases characterized by chronic neuroinflammation. Arch. Toxicol. 2017;91(4):1623\u20131634. doi: 10.1007/s00204-017-1939-4.", "ArticleIdList": ["10.1007/s00204-017-1939-4", "28204864"]}, {"Citation": "Sahebkar A., Saboni N., Pirro M., Banach M. Curcumin: an effective adjunct in patients with statin-associated muscle symptoms? Journal of Cachexia, Sarcopenia and Muscle. 2017;8(1):19\u201324. doi: 10.1002/jcsm.12140.", "ArticleIdList": ["10.1002/jcsm.12140", "PMC5326825", "27897416"]}, {"Citation": "Moher D., Liberati A., Tetzlaff J., Altman D.G., Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7) doi: 10.1002/jcsm.12140.", "ArticleIdList": ["10.1002/jcsm.12140", "PMC2707599", "19621072"]}, {"Citation": "De Caires S., Steenkamp V. Use of Yokukansan (TJ\u201054) in the treatment of neurological disorders: a review. Phyther. Res. 2010;24(9):1265\u20131270. doi: 10.1002/ptr.3146.", "ArticleIdList": ["10.1002/ptr.3146", "20812276"]}, {"Citation": "Iwasaki K., Kobayashi S., Chimura Y., Taguchi M., Inoue K., Cho S., Akiba T., et al. A randomized, double\u2010blind, placebo\u2010controlled clinical trial of the Chinese herbal medicine \u2018ba wei di huang wan\u2019 in the treatment of dementia. J. Am. Geriatr. Soc. 2004;52(9):1518\u20131521. doi: 10.1111/j.1532-5415.2004.52415.x.", "ArticleIdList": ["10.1111/j.1532-5415.2004.52415.x", "15341554"]}, {"Citation": "Iwasaki K., Satoh-Nakagawa T., Maruyama M., Monma Y., Nemoto M., Tomita N., et al. A randomized, observer-blind, controlled trial of the traditional Chinese medicine Yi-Gan San for improvement of behavioral and psychological symptoms and activities of daily living in dementia patients. J. Clin. Psychiatry. 2005;66(2) doi: 10.4088/jcp.v66n0214.", "ArticleIdList": ["10.4088/jcp.v66n0214", "15705012"]}, {"Citation": "Wake R., Miyaoka T., Furuya M., Hashioka S., Horiguchi J. Effects of yokukansan, a Japanese kampo medicine for symptoms associated autism spectrum disorder. CNS Neurol. Disord. - Drug Targets. 2016;66(2):248\u2013252. doi: 10.2174/1871527315666160413120541.", "ArticleIdList": ["10.2174/1871527315666160413120541", "27071791"]}, {"Citation": "Miyaoka T., Furuya M., Horiguchi J., Wake R., Hashioka S., Tohyama M., et al. Efficacy and safety of yokukansan in treatment-resistant schizophrenia: a randomized, multicenter, double-blind, placebo-controlled trial, Evidence-based Complement. Alternative Med. 2015;232(1):155\u2013164. doi: 10.1155/2015/201592.", "ArticleIdList": ["10.1155/2015/201592", "PMC4411464", "25954314"]}, {"Citation": "Mizukami K., Asada T., Kinoshita T., Tanaka K., Sonohara K., Nakai R., et al. A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia. Int. J. Neuropsychopharmacol. 2009;12(2):191\u2013199. doi: 10.1017/S146114570800970X.", "ArticleIdList": ["10.1017/S146114570800970X", "19079814"]}, {"Citation": "Shigenobu K., Ikeda M., Fukuhara R., Maki N., Hokoishi K., Nebu A., et al. The Stereotypy Rating Inventory for frontotemporal lobar degeneration. Psychiatr. Res. 2002;110(2):175\u2013187. doi: 10.1016/s0165-1781(02)00094-x.", "ArticleIdList": ["10.1016/s0165-1781(02)00094-x", "12057829"]}, {"Citation": "Kimura T., Hayashida H., Furukawa H., Takamatsu J. Pilot study of pharmacological treatment for frontotemporal dementia: effect of Yokukansan on behavioral symptoms. Psychiatr. Clin. Neurosci. 2010;64(2):207\u2013210. doi: 10.1111/j.1440-1819.2010.02072.x.", "ArticleIdList": ["10.1111/j.1440-1819.2010.02072.x", "20447015"]}, {"Citation": "Bockaert J., Claeysen S., B\u00e9camel C., Dumuis A., Marin P. Neuronal 5-HT metabotropic receptors: fine-tuning of their structure, signaling, and roles in synaptic modulation. Cell Tissue Res. 2006;326(2):553\u2013572. doi: 10.1007/s00441-006-0286-1.", "ArticleIdList": ["10.1007/s00441-006-0286-1", "16896947"]}, {"Citation": "Roth B.L. Multiple serotonin receptors: clinical and experimental aspects. Ann. Clin. Psychiatr. 1994;6(2):67\u201378. doi: 10.3109/10401239409148985.", "ArticleIdList": ["10.3109/10401239409148985", "7804391"]}, {"Citation": "Baumgarten H.G., Grozdanovic Z. Psychopharmacology of central serotonergic systems. Pharmacopsychiatry. 1995;28(2):73\u201379. doi: 10.1055/s-2007-979623.", "ArticleIdList": ["10.1055/s-2007-979623", "8614704"]}, {"Citation": "Lesch K.P., Gutknecht L. Focus on the 5-HT1A receptor: emerging role of a gene regulatory variant in psychopathology and pharmacogenetics. Int. J. Neuropsychopharmacol. 2004;7(4):381\u2013385. doi: 10.1017/S1461145704004845.", "ArticleIdList": ["10.1017/S1461145704004845", "15683551"]}, {"Citation": "Sharp T., Boothman L., Raley J., Qu\u00e9r\u00e9e P. Important messages in the \u2018post\u2019: recent discoveries in 5-HT neurone feedback control. Trends Pharmacol. Sci. 2007;2812:629\u2013636. doi: 10.1016/j.tips.2007.10.009.", "ArticleIdList": ["10.1016/j.tips.2007.10.009", "17996955"]}, {"Citation": "Lai M.K., Tsang S.W., Francis P.T., Esiri M.M., Keene J., Hope T., Chen C.P. Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease. Brain Res. 2003;9741\u20132:82\u201387. doi: 10.1016/s0006-8993(03)02554-x.", "ArticleIdList": ["10.1016/s0006-8993(03)02554-x", "12742626"]}, {"Citation": "Kanatani H., Kohda H., Yamasaki K., Hotta I., Nakata Y., Segawa T., Yamanaka E., Aimi N., Sakai S. The active principles of the branchlet and hook of Uncaria sinensis Oliv. examined with a 5-hydroxytryptamine receptor binding assay. J. Pharm. Pharmacol. 1985;37(6):401\u2013404. doi: 10.1111/j.2042-7158.1985.tb03023.x.", "ArticleIdList": ["10.1111/j.2042-7158.1985.tb03023.x", "2862262"]}, {"Citation": "Murakami Y., Zhao Q., Harada K., Tohda M., Watanabe H., Matsumoto K. Choto-san, a Kampo formula, improves chronic cerebral hypoperfusion-induced spatial learning deficit via stimulation of muscarinic M1 receptor. Pharmacol. Biochem. Behav. 2005;81(3):616\u2013625. doi: 10.1016/j.pbb.2005.05.004.", "ArticleIdList": ["10.1016/j.pbb.2005.05.004", "15936808"]}, {"Citation": "Drevets W.C., Thase M.E., Moses-Kolko E.L., Price J., Frank E., Kupfer D.J., Mathis C. Serotonin-1A receptor imaging in recurrent depression: replication and literature review. Nucl. Med. Biol. 2007;34(7):865\u2013877. doi: 10.1016/j.nucmedbio.2007.06.008.", "ArticleIdList": ["10.1016/j.nucmedbio.2007.06.008", "PMC2702715", "17921037"]}, {"Citation": "Egashira N., Iwasaki K., Ishibashi A., Hayakawa K., Okuno R., Abe M., Uchida N., et al. Repeated administration of Yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT) 2A receptors in the prefrontal cortex. Prog. Neuro-Psychopharmacol. Biol. Psychiatry. 2008;32(6):1516\u20131520. doi: 10.1016/j.pnpbp.2008.05.010.", "ArticleIdList": ["10.1016/j.pnpbp.2008.05.010", "18558456"]}, {"Citation": "Fayerman . Jul. 2012. The Souvenaid Memory Drink: what Alzheimer's Experts Say about the M.I.T.-patented Elixir, Vancouver Sun."}, {"Citation": "Scheltens P., Twisk J.W., Blesa R., Scarpini E., von Arnim C.A., Bongers A., Harrison J., Swinkels S.H., Stam C.J., de Waal H., Wurtman R.J., Wieggers R.L., Vellas B., Kamphuis P.J. Efficacy of Souvenaid in mild Alzheimer's disease: results from a randomized, controlled trial. J. Alzheimers. Dis. 2012;31(1):225\u2013236. doi: 10.3233/JAD-2012-121189.", "ArticleIdList": ["10.3233/JAD-2012-121189", "22766770"]}, {"Citation": "Van Wijk N., Broersen L.M., de Wilde M.C., Hageman R.J., Groenendijk M., Sijben J.W., Kamphuis P.J. Targeting synaptic dysfunction in Alzheimer's disease by administering a specific nutrient combination. J Alzheimers Dis. 2014;38:459\u2013479. doi: 10.3233/JAD-130998.", "ArticleIdList": ["10.3233/JAD-130998", "23985420"]}, {"Citation": "Chicago: Phase 2 News\u2014Therapeutic Breakfast Food? | ALZFORUM."}, {"Citation": "Richardson U.I., Watkins C.J., Pierre C., Ulus I.H., Wurtman R.J. Stimulation of CDP-choline synthesis by uridine or cytidine in PC12 rat pheochromocytoma cells. Brain Res. 2003;971(2):161\u2013167. doi: 10.1016/s0006-8993(03)02333-3.", "ArticleIdList": ["10.1016/s0006-8993(03)02333-3", "12706232"]}, {"Citation": "Sakamoto T., Cansev M., Wurtman R. Oral supplementation with docosahexaenoic acid and uridine-5\u2032-monophosphate increases dendritic spine density in adult gerbil hippocampus. Brain Res. 2007;1182:50\u201359. doi: 10.1016/j.brainres.2007.08.089.", "ArticleIdList": ["10.1016/j.brainres.2007.08.089", "PMC2140951", "17950710"]}, {"Citation": "SOUVENAID a Dietary Treatment for Mild Alzheimer\u2019S Disease. 1800."}, {"Citation": "Pardini M., Serrati C., Guida S., Mattei C., Abate L., Massucco D., Sassos D., Amore M., Krueger F., Cocito L., Emberti Gialloreti L. Souvenaid reduces behavioral deficits and improves social cognition skills in frontotemporal dementia: a proof-of-concept Study. Neurodegener. Dis. 2015;15(1):58\u201362. doi: 10.1159/000369811.", "ArticleIdList": ["10.1159/000369811", "25592742"]}, {"Citation": "Clare R., King V.G., Wirenfeldt M., Vinters H.V. Synapse loss in dementias. J. Neurosci. Res. 2010;88(10):2083. doi: 10.1002/JNR.22392.", "ArticleIdList": ["10.1002/JNR.22392", "PMC3068914", "20533377"]}, {"Citation": "Foster M., Sherrington C. A textbook of physiology. 1897;3"}, {"Citation": "Perea G., Navarrete M., Araque A. Tripartite synapses: astrocytes process and control synaptic information. Trends Neurosci. 2009;32(8):421\u2013431. doi: 10.1016/j.tins.2009.05.001.", "ArticleIdList": ["10.1016/j.tins.2009.05.001", "19615761"]}, {"Citation": "Missler M., S\u00fcdhof T.C., Biederer T. Synaptic cell adhesion. Cold Spring Harbor Perspect. Biol. 2012;4(4):a005694. doi: 10.1101/CSHPERSPECT.A005694.", "ArticleIdList": ["10.1101/CSHPERSPECT.A005694", "PMC3312681", "22278667"]}, {"Citation": "Vassallo N., Scerri C. Mediterranean diet and dementia of the Alzheimer type. Curr. Aging Sci. 2013;6:150\u2013162. doi: 10.2174/1874609811306020003.", "ArticleIdList": ["10.2174/1874609811306020003", "23030130"]}, {"Citation": "Gu Y., Schupf N., Cosentino S.A., Luchsinger J.A., Scarmeas N. Nutrient intake and plasma \u03b2-amyloid. Neurology. 2012;78(2):1832\u20131840. doi: 10.1212/WNL.0b013e318258f7c2. 3.", "ArticleIdList": ["10.1212/WNL.0b013e318258f7c2", "PMC3369517", "22551728"]}, {"Citation": "Lynch M.A. Long-term potentiation and memory. Physiol. Rev. 2004;84(1):87\u2013136. doi: 10.1152/physrev.00014.2003. PMID: 14715912.", "ArticleIdList": ["10.1152/physrev.00014.2003", "14715912"]}, {"Citation": "Zhongjin Z., Jinkui Yaolue Fanglun . English Edition. New World Press; Beijing, China: 1987. 2C or 3C AD (Han Dynasty). Luo XM."}, {"Citation": "Ba Wei Di Huang Wan Sun Ten Ba Wei Di Huang Wan (Jin Gui Shen Qi Wan) (722) 100 capsules | AcuAtlanta.net."}, {"Citation": "Hirokawa S., Nose M., Amagaya S., Oyama T., Ogihara Y. \u201cProtective effect of hachimi-jio-gan, an oriental herbal medicinal mixture, against cerebral anoxia. J. Ethnopharmacol. 1993;40(3):201\u2013206. doi: 10.1016/0378-8741(93)90069-h.", "ArticleIdList": ["10.1016/0378-8741(93)90069-h", "8145576"]}, {"Citation": "Hirokawa S., Nose M., Ishige A., Amagaya S., Oyama T., Ogihara Y. Effect of Hachimi-jio-gan on scopolamine-induced memory impairment and on acetylcholine content in rat brain. J. Ethnopharmacol. 1996;50(2):77\u201384. doi: 10.1016/0378-8741(95)01332-6.", "ArticleIdList": ["10.1016/0378-8741(95)01332-6", "8866727"]}, {"Citation": "Isobe H., Yamamoto K., Cyong J.C. Effects of Hachimi-jio-gan (Ba-wei-di-huang-wan) on blood flow in the human central retinal artery. Am. J. Chin. Med. 2003;31(3):425\u2013435. doi: 10.1142/S0192415X03001181.", "ArticleIdList": ["10.1142/S0192415X03001181", "12943173"]}, {"Citation": "Picciotto M., Higley M., Mineur Y. Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior. Neuron. 2012;76(1):116\u2013129. doi: 10.1016/j.neuron.2012.08.036.", "ArticleIdList": ["10.1016/j.neuron.2012.08.036", "PMC3466476", "23040810"]}, {"Citation": "Purves, Dale G., Augustine D., Fitzpatrick L., Katz A., LaMantia J., McNamara, et al. Sunderland (Ma) Sinauer Associates. Types of Eye Movements and Their Functions. 2001. Neuroscience. 2nd edition."}, {"Citation": "Contestabile A. The history of the cholinergic hypothesis. Behav. Brain Res. 2011;22(2):334\u2013340. doi: 10.1016/J.BBR.2009.12.044.", "ArticleIdList": ["10.1016/J.BBR.2009.12.044", "20060018"]}, {"Citation": "Tabet N. Acetylcholinesterase inhibitors for Alzheimer's disease: anti-inflammatories in acetylcholine clothing. Age Ageing. 2006;35(4):336\u2013338. doi: 10.1093/AGEING/AFL027.", "ArticleIdList": ["10.1093/AGEING/AFL027", "16788077"]}, {"Citation": "Raves M.L., Harel M., Pang Y.P., Silman I., Kozikowski A.P., Sussman J.L. Structure of acetylcholinesterase complexed with the nootropic alkaloid, (-)-huperzine A. Nat. Struct. Biol. 1997;4(1):57\u201363. doi: 10.1038/nsb0197-57.", "ArticleIdList": ["10.1038/nsb0197-57", "8989325"]}, {"Citation": "Erdogan Orhan I., Orhan G., Gurkas E. An overview on natural cholinesterase inhibitors - a multi-targeted drug class - and their mass production. Mini-Rev. Med. Chem. 2011;11(10):836\u2013842. doi: 10.2174/138955711796575434.", "ArticleIdList": ["10.2174/138955711796575434", "21762104"]}, {"Citation": "Bai D.L., Tang X.C., He X.C. Huperzine A, A potential therapeutic agent for treatment of Alzheimer's disease. Curr. Med. Chem. 2012;7(3):963\u2013968. doi: 10.2174/0929867003375281.", "ArticleIdList": ["10.2174/0929867003375281", "10637369"]}, {"Citation": "Yang G., Wang Y., Tian J., Liu J.P. Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials. PLoS One. 2013;8(9):1\u20138. doi: 10.1371/journal.pone.0074916.", "ArticleIdList": ["10.1371/journal.pone.0074916", "PMC3781107", "24086396"]}, {"Citation": "Xing S.H., Zhu C.X., Zhang R., An L. 2014. Huperzine A in the Treatment of Alzheimer's Disease and Vascular Dementia: A Meta-Analysis, Evidence-Based Complementary and Alternative Medicine; p. 2014.", "ArticleIdList": ["10.1155/2014/363985", "PMC3930088", "24639880"]}, {"Citation": "Picciotto M.R., Higley M.J., Mineur Y.S. Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior. Neuron. 2012;76(1):116\u2013129. doi: 10.1016/j.neuron.2012.08.036.", "ArticleIdList": ["10.1016/j.neuron.2012.08.036", "PMC3466476", "23040810"]}, {"Citation": "Qian Z.M., Ke Y., Huperzine A. Is it an effective disease-modifying drug for Alzheimer's disease? Front. Aging Neurosci. 2019;6(216):1\u20136. doi: 10.3389/fnagi.2014.00216.", "ArticleIdList": ["10.3389/fnagi.2014.00216", "PMC4137276", "25191267"]}, {"Citation": "Wang B.S., Wang H., Wei Z.H., Song Y.Y., Zhang L., Chen H.Z. Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis. J. Neural. Transm. 2009;116(4):457\u2013465. doi: 10.1007/s00702-009-0189-x.", "ArticleIdList": ["10.1007/s00702-009-0189-x", "19221692"]}, {"Citation": "Anon . National Germplasm Resources Laboratory; Beltsville, Maryland: 2012. Germplasm Resources Information Network (GRIN)., USDA, ARS, National Genetic Resources Program."}, {"Citation": "Aguiar S., Borowski T. Neuropharmacological review of the nootropic herb Bacopa monnieri. Rejuvenation Res. 2013;16(4):313\u2013326. doi: 10.1089/rej.2013.1431.", "ArticleIdList": ["10.1089/rej.2013.1431", "PMC3746283", "23772955"]}, {"Citation": "Gupta Richa, Pande Akshara, Gupta Amit, Yadav Rishika, Garg Navin, Sharmaet al. Aditi. AyurVirDB\u2019 Ayurvedic database for virus cure. Int. J. Ayurvedic Med. 2021;12(3):1\u20138. doi: 10.47552/ijam.v12i3.1955.", "ArticleIdList": ["10.47552/ijam.v12i3.1955"]}, {"Citation": "Kumar N., Abichandani L.G., Thawani V., Gharpure K.J., Naidu M.U.R., Venkat Ramana G. Efficacy of standardized extract of Bacopa monnieri (Bacognize\u00ae) on cognitive functions of medical students: a six-week, randomized placebo-controlled trial, evidence-based complement. Alternative Med. 2016:1\u20138. doi: 10.1155/2016/4103423. 4103423(2016.", "ArticleIdList": ["10.1155/2016/4103423", "PMC5075615", "27803728"]}, {"Citation": "Calabrese C., Gregory W.L., Leo M., Kraemer D., Bone K., Oken B. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial. J. Alternative Compl. Med. 2008;14(6):707\u2013713. doi: 10.1089/acm.2008.0018.", "ArticleIdList": ["10.1089/acm.2008.0018", "PMC3153866", "18611150"]}, {"Citation": "Dhanasekaran M., Tharakan B., Holcomb L.A., Hitt A.R., Young K.A., Manyam B.V. Neuroprotective mechanisms of ayurvedic antidementia botanical Bacopa monniera. Phyther. Res. 2007;21(10):965\u2013969. doi: 10.1002/ptr.2195.", "ArticleIdList": ["10.1002/ptr.2195", "17604373"]}, {"Citation": "Das A., Shanker G., Nath C., Pal R., Singh S., Singh H.K. A comparative study in rodents of standardized extracts of Bacopa monniera and Ginkgo biloba - anticholinesterase and cognitive enhancing activities. Pharmacol. Biochem. Behav. 2002;73(4):893\u2013900. doi: 10.1016/S0091-3057(02)00940-1.", "ArticleIdList": ["10.1016/S0091-3057(02)00940-1", "12213536"]}, {"Citation": "Emmanuvel Rajan K., Singh H.K., Parkavi A., Charles P.D. Attenuation of 1-(m-chlorophenyl)-biguanide induced hippocampus-dependent memory impairment by a standardised extract of Bacopa monniera (BESEB CDRI-08) Neurochem. Res. 2011;36(11):2136\u20132144. doi: 10.1007/s11064-011-0538-7.", "ArticleIdList": ["10.1007/s11064-011-0538-7", "21735137"]}, {"Citation": "Shahidi F., Ambigaipalan P. Omega-3 polyunsaturated fatty acids and their health benefits. Annu. Rev. Food Sci. Technol. 2018;9:345\u2013381. doi: 10.1146/annurev-food-111317-095850.", "ArticleIdList": ["10.1146/annurev-food-111317-095850", "29350557"]}, {"Citation": "Rochette L., Ghibu S., Muresan A., Vergely C. Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes. Can. J. Physiol. Pharmacol. 2015;93(12):2015. doi: 10.1139/cjpp-2014-0353.", "ArticleIdList": ["10.1139/cjpp-2014-0353", "26406389"]}, {"Citation": "Najafi N., Mehri S., Ghasemzadeh Rahbardar M., Hosseinzadeh H. Effects of alpha lipoic acid on metabolic syndrome: a comprehensive review. Phytother Res. 2022;36(6):2300\u20132323. doi: 10.1002/ptr.7406.", "ArticleIdList": ["10.1002/ptr.7406", "35234312"]}, {"Citation": "Williard D.E., Harmon S.D., Preuss M.A., Kaduce T.L., Moore S.A., Spector A.A. \u201cProduction and release of docosahexaenoic acid by differentiated rat brain astrocytes. World Rev. Nutr. Diet. 2001;88:168\u2013172. doi: 10.1159/000059781.", "ArticleIdList": ["10.1159/000059781", "11935950"]}, {"Citation": "Odabasoglu F., Halici Z., Aygun H., Halici M., Atalay F., Cakir A., et al. \u03b1-Lipoic acid has anti-inflammatory and anti-oxidative properties: an experimental study in rats with carrageenan-induced acute and cotton pellet-induced chronic inflammations. Br. J. Nutr. 2011;105(1):31\u201343 2011. doi: 10.1017/S0007114510003107.", "ArticleIdList": ["10.1017/S0007114510003107", "21073761"]}, {"Citation": "Shinto L., Quinn J., Montine T., Dodge H.H., Woodward W., Baldauf-Wagner S., et al. A randomized placebo-controlled pilot trial of omega-3 fatty acids and alpha lipoic acid in Alzheimer's disease. J. Alzheim. Dis. 2014;38(1):111\u2013120. doi: 10.3233/JAD-130722.", "ArticleIdList": ["10.3233/JAD-130722", "PMC3886557", "24077434"]}, {"Citation": "Carlson S.E. \u201cocosahexaenoic acid and arachidonic acid in infant development. Semin. Neonatol. 2001;6(5) doi: 10.1053/siny.2001.0093.", "ArticleIdList": ["10.1053/siny.2001.0093", "11988033"]}, {"Citation": "McCann J.C., Ames B.N. Is docosahexaenoic acid, an n-3 long-chain polyunsaturated fatty acid, required for development of normal brain function? An overview of evidence from cognitive and behavioral tests in humans and animals. Am. J. Clin. Nutr. 2005;82(2):281\u2013295. doi: 10.1093/ajcn.82.2.281.", "ArticleIdList": ["10.1093/ajcn.82.2.281", "16087970"]}, {"Citation": "Siedlak S.L., Casadesus G., Webber K.M., Pappolla M.A., Atwood C.S., Smith M.A., et al. Chronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease. Free Radic. Res. 2009;43(2):156\u2013164. doi: 10.1080/10715760802644694.", "ArticleIdList": ["10.1080/10715760802644694", "PMC2675191", "19160110"]}, {"Citation": "Gamblin T.C., King M.E., Kuret J., Berry R.W., Binder L.I. Oxidative regulation of fatty acid-induced tau polymerization. Biochemistry. 2000;39(46):14203\u201314210. doi: 10.1021/bi001876l.", "ArticleIdList": ["10.1021/bi001876l", "11087369"]}, {"Citation": "Liu Y., Zhang Q., Wang L., Wang H., Sun T., Xia H., et al. The \u03b1-lipoic acid improves high-fat diet-induced cerebral damage through inhibition of oxidative stress and inflammatory reaction. Environ. Toxicol. Pharmacol. 2017;56:219\u2013224. doi: 10.1016/j.etap.2017.09.018.", "ArticleIdList": ["10.1016/j.etap.2017.09.018", "28985617"]}, {"Citation": "Cole G.M., Frautschy S.A. Docosahexaenoic acid protects from amyloid and dendritic pathology in an Alzheimer's disease mouse model. Nutr. Health (Bicester) 2006;18(3):249\u2013259. doi: 10.1177/026010600601800307.", "ArticleIdList": ["10.1177/026010600601800307", "17180870"]}, {"Citation": "Venigalla M., Sonego S., Gyengesi E., Sharman M.J., M\u00fcnch G. Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer's disease. Neurochem. Int. 2016;95(6):63\u201374. doi: 10.1016/j.neuint.2015.10.011.", "ArticleIdList": ["10.1016/j.neuint.2015.10.011", "26529297"]}, {"Citation": "Nau R., Ribes S., Djukic M., Eiffert H. Strategies to increase the activity of microglia as efficient protectors of the brain against infections. Front. Cell. Neurosci. 2014;8:138. doi: 10.3389/fncel.2014.00138.", "ArticleIdList": ["10.3389/fncel.2014.00138", "PMC4033068", "24904283"]}, {"Citation": "Bronzuoli M.R., Facchinetti R., Steardo L., Jr., Romano A., Stecca C., Passarella S., et al. Palmitoylethanolamide dampens reactive astrogliosis and improves neuronal trophic support in a triple transgenic model of Alzheimer's disease: in vitro and in vivo evidence. Oxid. Med. Cell. Longev. 2018:1\u201314. doi: 10.1155/2018/4720532. 2018.", "ArticleIdList": ["10.1155/2018/4720532", "PMC5822864", "29576849"]}, {"Citation": "Esposito E., Cuzzocrea S. Palmitoylethanolamide in homeostatic and traumatic central nervous system injuries. CNS Neurol. Disord. Targets (Formerly Curr. Drug Targets-CNS Neurol. Disord. 2013;12(1):55\u201361. doi: 10.2174/1871527311312010010.", "ArticleIdList": ["10.2174/1871527311312010010", "23394520"]}, {"Citation": "Scuderi C., Stecca C., Valenza M., Ratano P., Bronzuoli M.R., Bartoli S., Steardo L., et al. Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer's disease. Cell Death Dis. 2014;5(9):ne1419. doi: 10.1038/cddis.2014.376. \u2013e1419.", "ArticleIdList": ["10.1038/cddis.2014.376", "PMC4540191", "25210802"]}, {"Citation": "De Palma L., Mato A.S., Monitillo V., Fiore P. Co-ultramicronized palmitoylethanolamide/luteolin treatment as add-on to intensive neuro-rehabilitation in a young patient with traumatic brain injury. Gazz. MEDICA Ital. Arch. PER LE Sci. MEDICHE. 2018;177(5):237\u2013242. doi: 10.1111/bph.12907.", "ArticleIdList": ["10.1111/bph.12907"]}, {"Citation": "Borrelli F., Romano B., Petrosino S., Pagano E., Capasso R., Coppola D., et al. Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti\u2010inflammatory agent. Br. J. Pharmacol. 2015;172(1):142\u2013158. doi: 10.1111/bph.12907.", "ArticleIdList": ["10.1111/bph.12907", "PMC4280974", "25205418"]}, {"Citation": "Petrosino S., Di Marzo V. The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations. Br. J. Pharmacol. 2017;174(11):1349\u20131365. doi: 10.1111/bph.13580.", "ArticleIdList": ["10.1111/bph.13580", "PMC5429331", "27539936"]}, {"Citation": "Bertolino B., Crupi R., Impellizzeri D., Bruschetta G., Cordaro M., Siracusa R., et al. Beneficial effects of Co-ultramicronized palmitoylethanolamide/luteolin in a mouse model of autism and in a case report of autism. CNS Neurosci. Ther. 2017;23(1):87\u201398. doi: 10.1111/cns.12648.", "ArticleIdList": ["10.1111/cns.12648", "PMC6492645", "27701827"]}, {"Citation": "Assogna M., Di Lorenzo F., Martorana A., Koch G. Synaptic effects of palmitoylethanolamide in neurodegenerative disorders. Biomolecules. 2022;12(8):1\u201316. doi: 10.3390/biom12081161.", "ArticleIdList": ["10.3390/biom12081161", "PMC9405819", "36009055"]}, {"Citation": "Assogna M., Casula E.P., Borghi I., Bonn\u00ec S., Sam\u00e0 D., Motta C., et al. Effects of palmitoylethanolamide combined with luteoline on frontal lobe functions, high frequency oscillations, and GABAergic transmission in patients with frontotemporal dementia. J. Alzheim. Dis. 2020;76(4):1297\u20131308. doi: 10.3233/JAD-200426.", "ArticleIdList": ["10.3233/JAD-200426", "32623398"]}, {"Citation": "Kamminga J., Kumfor F., Burrell J.R., Piguet O., Hodges J.R., Irish M. Differentiating between right-lateralised semantic dementia and behavioural-variant frontotemporal dementia: an examination of clinical characteristics and emotion processing. J. Neurol. Neurosurg. Psychiatry. 2015;86(10):1082\u20131088. doi: 10.1136/jnnp-2014-309120.", "ArticleIdList": ["10.1136/jnnp-2014-309120", "25511791"]}, {"Citation": "Zarei S., Carr K., Reiley L., Diaz K., Guerra O., Altamirano P.F., et al. A comprehensive review of amyotrophic lateral sclerosis. Surg. Neurol. Int. 2015;6(171):1\u201323. doi: 10.4103/2152-7806.169561.", "ArticleIdList": ["10.4103/2152-7806.169561", "PMC4653353", "26629397"]}, {"Citation": "Musella A., Fresegna D., Rizzo F.R., Gentile A., Bullitta S., De Vito F., et al. A novel crosstalk within the endocannabinoid system controls GABA transmission in the striatum. Sci. Rep. 2017;7(1):7363. doi: 10.1038/s41598-017-07519-8.", "ArticleIdList": ["10.1038/s41598-017-07519-8", "PMC5544685", "28779174"]}, {"Citation": "McDonald A.J., Mascagni F. Colocalization of calcium-binding proteins and GABA in neurons of the rat basolateral amygdala. Neuroscience. 2001;105(3) doi: 10.1016/S0306-4522(01)00214-7.", "ArticleIdList": ["10.1016/S0306-4522(01)00214-7", "11516833"]}, {"Citation": "Gonzalez-Burgos G., Lewis D.A. GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr. Bull. 2008;34(5):944\u2013961. doi: 10.1093/schbul/sbn070.", "ArticleIdList": ["10.1093/schbul/sbn070", "PMC2518635", "18586694"]}, {"Citation": "Wright T.M. Tramiprosate., Drugs of Today (Barcelona, Spain. 1998;42(5):291\u2013298. doi: 10.1358/dot.2006.42.5.973584. 2006.", "ArticleIdList": ["10.1358/dot.2006.42.5.973584", "16801992"]}, {"Citation": "Aisen P.S., Gauthier S., Vellas B., Briand R., Saumier D., Laurin J., et al. Alzhemed: a potential treatment for Alzheimer's disease. Curr. Alzheimer Res. 2007;4(4):473\u2013478. doi: 10.2174/156720507781788882.", "ArticleIdList": ["10.2174/156720507781788882", "17908052"]}, {"Citation": "Gauthier S., Aisen P.S., Ferris S.H., Saumier D., Duong A., Haine D., et al. Effect of tramiprosate in patients with mild-to-moderate Alzheimer's disease: exploratory analyses of the MRI sub-group of the Alphase study. JNHA-The J. Nutr. Heal. Aging. 2009;13:550\u2013557. doi: 10.1007/s12603-009-0106-x.", "ArticleIdList": ["10.1007/s12603-009-0106-x", "19536424"]}, {"Citation": "Martorana A., Di Lorenzo F., Manenti G., Semprini R., Koch G. Homotaurine induces measurable changes of short latency afferent inhibition in a group of mild cognitive impairment individuals. Front. Aging Neurosci. 2014;6(254):1\u201377. doi: 10.3389/fnagi.2014.00254.", "ArticleIdList": ["10.3389/fnagi.2014.00254", "PMC4172065", "25295005"]}, {"Citation": "Shankar G.M., Li S., Mehta T.H., Garcia-Munoz A., Shepardson N.E., Smith I., Brett F.M., et al. Amyloid-\u03b2 protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 2008;14(8):837\u2013842. doi: 10.1038/nm1782.", "ArticleIdList": ["10.1038/nm1782", "PMC2772133", "18568035"]}, {"Citation": "Palop J.J., Mucke L. Amyloid-\u03b2\u2013induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat. Neurosci. 2010;13(7):812\u2013818. doi: 10.1038/nn.2583.", "ArticleIdList": ["10.1038/nn.2583", "PMC3072750", "20581818"]}, {"Citation": "Gervais F., Paquette J., Morissette C., Krzywkowski P., Yu M., Azzi M., et al. Targeting soluble A\u03b2 peptide with Tramiprosate for the treatment of brain amyloidosis. Neurobiol. Aging. 2007;28(4):537\u2013547. doi: 10.1016/j.neurobiolaging.2006.02.015.", "ArticleIdList": ["10.1016/j.neurobiolaging.2006.02.015", "16675063"]}]}], "History": [{"Year": "2023", "Month": "2", "Day": "11"}, {"Year": "2024", "Month": "2", "Day": "25"}, {"Year": "2024", "Month": "2", "Day": "26"}, {"Year": "2024", "Month": "3", "Day": "27", "Hour": "6", "Minute": "45"}, {"Year": "2024", "Month": "3", "Day": "27", "Hour": "6", "Minute": "44"}, {"Year": "2024", "Month": "3", "Day": "27", "Hour": "3", "Minute": "50"}, {"Year": "2024", "Month": "2", "Day": "27"}], "PublicationStatus": "epublish", "ArticleIdList": ["38533051", "PMC10963206", "10.1016/j.heliyon.2024.e27233", "S2405-8440(24)03264-X"]}}]}